AU2001261022A1 - Combination therapy for treatment of depression comprising an antidepressant and an ampa receptor potentiator - Google Patents

Combination therapy for treatment of depression comprising an antidepressant and an ampa receptor potentiator

Info

Publication number
AU2001261022A1
AU2001261022A1 AU2001261022A AU6102201A AU2001261022A1 AU 2001261022 A1 AU2001261022 A1 AU 2001261022A1 AU 2001261022 A AU2001261022 A AU 2001261022A AU 6102201 A AU6102201 A AU 6102201A AU 2001261022 A1 AU2001261022 A1 AU 2001261022A1
Authority
AU
Australia
Prior art keywords
antidepressant
depression
treatment
combination therapy
ampa receptor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001261022A
Inventor
Phil Skolnick
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of AU2001261022A1 publication Critical patent/AU2001261022A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2001261022A 2000-05-24 2001-05-11 Combination therapy for treatment of depression comprising an antidepressant and an ampa receptor potentiator Abandoned AU2001261022A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US20682500P 2000-05-24 2000-05-24
US60/206,825 2000-05-24
PCT/US2001/011768 WO2001089530A2 (en) 2000-05-24 2001-05-11 Combination therapy for treatment of depression comprising an antidepressant and an ampa receptor potentiator

Publications (1)

Publication Number Publication Date
AU2001261022A1 true AU2001261022A1 (en) 2001-12-03

Family

ID=22768136

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001261022A Abandoned AU2001261022A1 (en) 2000-05-24 2001-05-11 Combination therapy for treatment of depression comprising an antidepressant and an ampa receptor potentiator

Country Status (5)

Country Link
EP (1) EP1292311A2 (en)
JP (1) JP2004509843A (en)
AU (1) AU2001261022A1 (en)
CA (1) CA2410531A1 (en)
WO (1) WO2001089530A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1438036A2 (en) * 2001-10-12 2004-07-21 Eli Lilly And Company Use of sulfonamide derivatives as pharmaceuticals compounds
WO2014078568A1 (en) 2012-11-14 2014-05-22 The Johns Hopkins University Methods and compositions for treating schizophrenia

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6889274A (en) * 1973-05-17 1975-11-20 Astra Laekemedel Ab Treatment of neurological disorders
US4148896A (en) * 1978-02-22 1979-04-10 E. I. Du Pont De Nemours And Company Antidepressant combination

Also Published As

Publication number Publication date
EP1292311A2 (en) 2003-03-19
WO2001089530A3 (en) 2002-09-12
JP2004509843A (en) 2004-04-02
WO2001089530A2 (en) 2001-11-29
CA2410531A1 (en) 2001-11-29

Similar Documents

Publication Publication Date Title
PL373156A1 (en) Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
AU2001280440A1 (en) Treatment of human herpesviruses using hyperthermia
AU2001241236A1 (en) A therapeutic agent of osteoporosis comprising an active ingredient of quercetinderivatives
AU2002322719A1 (en) Delivery of therapeutic capable agents
AU7735200A (en) Treatment of tissue by application of energy and drugs
AU3891299A (en) Combination therapy for treatment of depression
AU2001289037A1 (en) Electrical stimulation of tissue for therapeutic and diagnostic purposes
EP1420797A4 (en) Dermal therapy using phosphate derivatives of electron transfer agents
AU2001269046A1 (en) Use of therapeutic benzamide derivatives
AU2001269314A1 (en) Therapeutic and prophylactic use of reduced forms of pharmaceutical compounds
IL153706A0 (en) Therapeutic preparation of anxiety neurosis or depression, and piperazine derivatives
AU2001265253A1 (en) Treatment of hiv using hyperthermia
AU2002231206A1 (en) Treatment of depression
AU3896900A (en) Treatment of pain
AU2001264920A1 (en) Therapeutic uses of il-1 receptor antagonist
AU3082401A (en) Therapy of psoriasis
AU2001261022A1 (en) Combination therapy for treatment of depression comprising an antidepressant and an ampa receptor potentiator
AU2000275035A1 (en) Therapeutic and prophylactic drugs of myopia
AU1490801A (en) Targeted delivery of therapeutic and diagnostic moieties
AU3760900A (en) Treatment of menstrual function
AU2001284380A1 (en) Therapeutic and cosmetic uses of heparanases
IL159789A0 (en) Active ingredient combination for pharmacological therapy of nicotine dependence
AU2002354856A1 (en) Active substance combination for medicamentous therapy of nicotine dependency
AU2001261023A1 (en) Use of an ampa receptor potentiator for the treatment of obesity
AU2002351798A1 (en) Methods and dosage forms for improving the bioavailability of therapeutic agents